Cargando…

Suppression of in vitro antibody synthesis by immunoglobulin-binding factor

Alloantigen-activated mouse T cells secrete a factor which binds to the Fc fragment of IgG and blocks complement (C) activation by IgG (immunoglobulin-binding factor, IBF). IBF was found to suppress the direct plaque-forming cell (PFC) response of mouse spleen cell cultures to sheep erythrocytes and...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1975
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189901/
https://www.ncbi.nlm.nih.gov/pubmed/1079850
_version_ 1782146723654664192
collection PubMed
description Alloantigen-activated mouse T cells secrete a factor which binds to the Fc fragment of IgG and blocks complement (C) activation by IgG (immunoglobulin-binding factor, IBF). IBF was found to suppress the direct plaque-forming cell (PFC) response of mouse spleen cell cultures to sheep erythrocytes and to dinitrophenylated aminoethyldextran (T- independent antigen). Purification of IBF by affinity chromatography on IgG-coated Sepharose columns led to an increase of the suppressive capacity with IgG, IgM, or Fab2 from IgG) the factor responsible for inhibiting the PFC response could not be dissociated from that responsible for the inhibitory activity of IBF on C-dependent hemolysis. No effect was seen when cultures were pretreated for 6 h, or when IBF was added at 72 h. These data are compatible with the view that IBF is a soluable mediator of suppressor T cells which may interfere with terminal differentiation of antibody-forming cell precursors.
format Text
id pubmed-2189901
institution National Center for Biotechnology Information
language English
publishDate 1975
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21899012008-04-17 Suppression of in vitro antibody synthesis by immunoglobulin-binding factor J Exp Med Articles Alloantigen-activated mouse T cells secrete a factor which binds to the Fc fragment of IgG and blocks complement (C) activation by IgG (immunoglobulin-binding factor, IBF). IBF was found to suppress the direct plaque-forming cell (PFC) response of mouse spleen cell cultures to sheep erythrocytes and to dinitrophenylated aminoethyldextran (T- independent antigen). Purification of IBF by affinity chromatography on IgG-coated Sepharose columns led to an increase of the suppressive capacity with IgG, IgM, or Fab2 from IgG) the factor responsible for inhibiting the PFC response could not be dissociated from that responsible for the inhibitory activity of IBF on C-dependent hemolysis. No effect was seen when cultures were pretreated for 6 h, or when IBF was added at 72 h. These data are compatible with the view that IBF is a soluable mediator of suppressor T cells which may interfere with terminal differentiation of antibody-forming cell precursors. The Rockefeller University Press 1975-08-01 /pmc/articles/PMC2189901/ /pubmed/1079850 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
Suppression of in vitro antibody synthesis by immunoglobulin-binding factor
title Suppression of in vitro antibody synthesis by immunoglobulin-binding factor
title_full Suppression of in vitro antibody synthesis by immunoglobulin-binding factor
title_fullStr Suppression of in vitro antibody synthesis by immunoglobulin-binding factor
title_full_unstemmed Suppression of in vitro antibody synthesis by immunoglobulin-binding factor
title_short Suppression of in vitro antibody synthesis by immunoglobulin-binding factor
title_sort suppression of in vitro antibody synthesis by immunoglobulin-binding factor
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189901/
https://www.ncbi.nlm.nih.gov/pubmed/1079850